Birgit Jaber
Impact in
- Genetics top 5%
- Neurogenetic and Muscular Disorders Research
-
- Pharmacovigilance and Adverse Drug Reactions
Papers in
- Genetics 10
- Neurogenetic and Muscular Disorders Research 10
-
- Pharmacovigilance and Adverse Drug Reactions 1
- Co-authors
- Heidemarie Kletzl (5 shared papers)Susan M. Hilton (1 shared paper)Katja Heinig (2 shared papers)Andreas Guenther (2 shared papers)Omar Khwaja (1 shared paper)Tobias Bergauer (1 shared paper)Agnès Poirier (1 shared paper)Anne Marquet (1 shared paper)
- Journals
- Neurology (4 papers)British Journal of Clinical Pharmacology (2 papers)The Lancet Neurology (1 paper)Neuromuscular Disorders (1 paper)Annals of Clinical and Translational Neurology (1 paper)
- Partner nations
- SwitzerlandUnited KingdomUnited States
In The Last Decade
Birgit Jaber
13 papers receiving 321 citations
Peers
Comparison fields: 5 of 40
- Genetics 245
- Toxicology 11
- Pharmacology 9
- Speech and Hearing 4
- Analytical Chemistry 8
Countries citing papers authored by Birgit Jaber
This map shows the geographic impact of Birgit Jaber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Birgit Jaber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Birgit Jaber more than expected).
Fields of papers citing papers by Birgit Jaber
This network shows the impact of papers produced by Birgit Jaber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Birgit Jaber. The network helps show where Birgit Jaber may publish in the future.
Co-authors
The 25 scholars most cited alongside Birgit Jaber, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 90 | |
| 2 | 2022 | 79 | |
| 3 | 2023 | 44 | |
| 4 | 2020 | 31 | |
| 5 | 2014 | 28 | |
| 6 | 1995 | 21 | |
| 7 | 2024 | 17 | |
| 8 | 2025 | 17 | |
| 9 | 2022 | 8 | |
| 10 | 2021 | 4 | |
| 11 | 2020 | 3 | |
| 12 | 2024 | 3 | |
| 13 | 2024 | 1 | |
| 14 | 2023 | 0 |
About Birgit Jaber
Birgit Jaber is a scholar working on Genetics, Toxicology, Pharmacology, Ophthalmology and Pediatrics, Perinatology and Child Health, having authored 14 papers that have together received 346 indexed citations. Recurring topics across this work include Neurogenetic and Muscular Disorders Research (10 papers), Muscle Physiology and Disorders (1 paper), Pharmacogenetics and Drug Metabolism (1 paper), Pharmacovigilance and Adverse Drug Reactions (1 paper), Drug-Induced Ocular Toxicity (1 paper), Pharmaceutical studies and practices (1 paper) and Rheumatoid Arthritis Research and Therapies (1 paper). The work is most often cited by research in Genetics (245 citations), Toxicology (11 citations), Pharmacology (9 citations), Speech and Hearing (4 citations) and Analytical Chemistry (8 citations). Birgit Jaber has collaborated with scholars based in Switzerland, United Kingdom and United States. Frequent co-authors include Heidemarie Kletzl, Susan M. Hilton, Katja Heinig, Andreas Guenther, Omar Khwaja, Tobias Bergauer, Agnès Poirier, Anne Marquet, Hasane Ratni and Nicolas Frances. Their work appears in journals such as Neurology, British Journal of Clinical Pharmacology, The Lancet Neurology, Neuromuscular Disorders and Annals of Clinical and Translational Neurology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.